HSBC TUR.WAR.OP.END. RME/ DE000HS8UZ17 /
2024-10-07 1:35:09 PM | Chg.- | Bid3:34:27 PM | Ask3:34:25 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.0200EUR | - | - Bid Size: 25,000 |
- Ask Size: 25,000 |
ResMed Inc | 233.4285 - | 2078-12-31 | Call |
GlobeNewswire
08-28
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
GlobeNewswire
08-15
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader ...
GlobeNewswire
07-25
NATIONAL CENTER ON SHAKEN BABY SYNDROME AND XEALTH INCREASE SPEED AND ACCESSIBILITY OF CRITICAL PARE...
GlobeNewswire
06-27
XEALTH LAUNCHES DEWEY, THE INDUSTRY’S FIRST PERFORMANCE-BASED, DIGITAL HEALTH BENCHMARKING TOOL
GlobeNewswire
06-10
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep A...
GlobeNewswire
05-23
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provid...
GlobeNewswire
05-16
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and ...
GlobeNewswire
05-16
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
05-07
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS